Fig. 4From: NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcomeDisease free survival (DFS) (a–c) and overall survival (OS) (d–f) of 66 leukemia patients divided according to the level of NPM1.1 (a, d), NPM1.2 (b, e) and NPM1.3 (c, f) transcripts. Log-rank test p values < 0.05 indicate statistically significant differences between two curvesBack to article page